JDRF: Kellogg Family Early-Career Patient-Oriented Diabetes Research Awards Grant
Funding Amount
Up to US $1,000,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Institutional Eligibility:Domestic & foreign non-profit organizations; public & private universities, colleges, hospitals, laboratories; units of state & local governments; eligible agencies of the federal government.
- For the purposes of this award, clinical research is defined as research conducted with human subjects for which the investigator directly interacts with the subjects.
- The applicant must be sponsored by an investigator who is affiliated full-time with an accredited institution, who pursues clinical research, and who agrees to supervise the applicant’s training.
Other requirements
- Applicant Eligibility:In most cases, applicant will have an MD, MD-PhD or PsyD, hold an appointment or joint appointment in a subspecialty of clinical medicine, and conduct human clinical research.
- The Early Career Patient-Oriented Diabetes Research Award is intended for clinical researchers at a relatively early stage of their independent career.
- Clinical researchers who have received their first faculty-level appointment less than 5 years before the submission date are eligible to apply for this award.
- Applicants must have an MD or MD-PhD or PsyD, hold an appointment or joint appointment in a subspecialty of clinical medicine in a clinical department, and conduct human clinical research.
Overview
The JDRF Kellogg Family Early-Career Patient-Oriented Diabetes Research Awards support early-career investigators in diabetes-related clinical research. These awards, up to $200,000 annually for five years, aim to facilitate the transition to independent research roles. Eligible applicants typically hold an MD, MD-PhD, or PsyD, and must conduct human clinical research. JDRF encourages diverse applicants, including those affected by personal circumstances or COVID-related delays, to apply for this vital funding opportunity.
NOTE: Applications in the area of LONG-TERM COMPLICATIONS will not be accepted. Applications in Psychosocial and Behavioral Health will be accepted.
Kellogg Family Early Career Patient-Oriented Diabetes Research Award
Designed to provide crucial support to investigators who plan to pursue a career in diabetesrelated clinical investigation. Awards are made in the later stages of training and include the ability for recipients to transition to independent faculty or research appointments.
Funding
200,000 USD maximum/year for up to 5 years, including up to 10% for indirect costs and generally not renewable after 5 years.
Eligibility
Institutional Eligibility:Domestic & foreign non-profit organizations; public & private universities, colleges, hospitals, laboratories; units of state & local governments; eligible agencies of the federal governmentApplicant Eligibility:In most cases, applicant will have an MD, MD-PhD or PsyD, hold an appointment or joint appointment in a subspecialty of clinical medicine, and conduct human clinical researchThe Early Career Patient-Oriented Diabetes Research Award is intended for clinical researchers at a relatively early stage of their independent career. Clinical researchers who have received their first faculty-level appointment less than 5 years before the submission date are eligible to apply for this award.For the purposes of this award, clinical research is defined as research conducted with human subjects for which the investigator directly interacts with the subjects. Applicants must have an MD or MD-PhD or PsyD, hold an appointment or joint appointment in a subspecialty of clinical medicine in a clinical department, and conduct human clinical research. In exceptional circumstances, non-MD candidates will be considered if their work is likely to contribute significantly to a clinical outcome.JDRF is sensitive to personal and COVID-related matters that impact career trajectories. Applicants who have taken leave from their career (e.g. parenting of a child, childbirth, long-term care of a parent/spouse/child/dependent, personal health issues) or experienced a delay due to COVID shutdowns and the cancellation of the Breakthrough T1D
FY21 ECPOR call that puts them outside of the eligibility time frame for the award mechanism should feel free to reach out to Breakthrough T1D staff ahead of their application submission. Breakthrough T1D aims to be flexible and adjust these time frames if necessary and as appropriate.For a project proposing Human Subject Research, please review the Scientific Guidelines.The applicant must be sponsored by an investigator who is affiliated full-time with an accredited institution, who pursues clinical research, and who agrees to supervise the applicant’s training. The sponsor does not necessarily need to have a background in diabetes, but the research project must be type 1 diabetes-related and patient-oriented.
What Breakthrough T1D actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 100
- Total given
- $79.32M
- Median grant
- $378K
- Range
- $25K–$7.28M
- By dollars: Massachusetts 21%, California 13%, Florida 7%. Top recipient cities: Boston, MA; New York, NY; Seattle, WA.
- 0% of grants with a stated purpose were for general or operating support.
- 16% of recipients were new grantees, not repeat recipients.
Example grants
University of Massachusetts Medical School · Worcester, MA
T1d research
$7.28M
The Regents of the University of California San Francisco · San Francisco, CA
T1d research
$5.4M
The University of Chicago · Chicago, IL
T1d research
$4.12M
Regents of the University of Colorado · Denver, CO
T1d research
$3.58M
University of Florida · Gainesville, FL
T1d research
$3.13M
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
RFA- Advancing Genetic Risk Assessment for Type 1 Diabetes: Improving Prediction and Clinical Translation Grant
Breakthrough T1D
Amount
Up to US $900,000
Deadline
Deadline not published
Breakthrough T1D- Innovative Awards Grant
Breakthrough T1D
Amount
Up to US $200,000
Deadline
Deadline not published
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health
Amount
$40,000,000 total
Deadline
November 10, 2026
DoW Vision, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$4,400,000 total
Deadline
November 12, 2026
DoW Vision, Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$1,600,000 total
Deadline
November 12, 2026
Ready to apply for JDRF: Kellogg Family Early-Career Patient-Oriented Diabetes Research Awards Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found JDRF: Kellogg Family Early-Career Patient-Oriented Diabetes Research Awards Grant. Now let's win it.